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Abstract
Introduction: We present a case of nonseminomatous germ cell tumor of the testes with acute urinary retention
secondary to urethral metastasis. This presentation, and similar cases of urethral metastasis from this tumor, have
not been reported previously.
Case presentation: A 35-year-old Caucasian man presented to hospital with a history of acute urinary retention.
On examination he was found to have right testicular enlargement with raised b-human chorionic gonadotrophin,
serum a-fetoprotein and lactate dehydrogenase levels. He underwent radical left inguinal orchidectomy and
histology confirmed a nonseminomatous germ cell tumor of the testes. Cystoscopy carried out due to urinary
retention showed penile metastasis and the biopsy confirmed metastatic malignant undifferentiated teratoma.
Staging computed tomography scan and magnetic resonance imaging of the pelvis showed pulmonary, pelvic
nodal, ischial and penile metastasis. The diagnosis of the International Germ Cell Cancer Collaborative Group of
poor prognosis metastatic nonseminomatous germ cell tumor was made, following which he received four cycles
of bleomycin, etoposide and cisplatin chemotherapy with curative intent. He had a complete marker and an
excellent radiological response. He is currently under follow up.
Conclusion: The unusual presentation of lymphovascular spread in this case of nonseminomatous germ cell tumor
highlights the need to include routine pelvic imaging in the assessment and follow up of testicular cancer.
Introduction
We report the case of a Caucasian man who presented
with acute urinary retention and was found to have ure-
thral metastasis from a nonseminomatous germ cell
tumor. Urethral metastasis from a nonseminomatous
germ cell tumor is very unusual, as it does not lie in the
lymphatic drainage pathway of the testis.
Case presentation
A 35-year-old Caucasian man presented to his local gen-
eral hospital emergency department with a history of
acute urinary retention. He had a background history of
grade 1 astrocytoma in the posterior fossa at the age of
six that was resected in 1979, and required re-excision in
1982 followed by radiotherapy resulting in residual
hydrocephalus, epilepsy and mild learning difficulties.
There was no history of testicular maldescent,
orchidopexy or other inguino-scrotal surgery. On exami-
nation he was found to have no new neurological deficits,
but right testicular enlargement was noted. An ultra-
sound study confirmed a 9×8 cm heterogeneous mass
replacing the body of the right testis. His serum b-human
chorionic gonadotrophin level was 5047 U/L (normal
range 0 to 5 U/L), serum a-fetoprotein level was 7413
kU/L (normal range 3 to 8 kU/L) and lactate dehydrogen-
ase level was 1452 IU/L (normal range 230 to 460 IU/L).
His liver and renal biochemistry was normal.
A urethral catheter was placed, and drained normal
urine. He underwent a radical left inguinal orchidectomy
five days later. Histology indicated a non-seminomatous
germ cell tumor, with predominantly yolk sac tumor and
small amounts of undifferentiated teratoma. The overall
histological diagnosis was malignant teratoma intermediate
(British Testicular Tumour Panel (BTTP) classification) or
embryonal carcinoma (World Health Organization (WHO)
classification). Lymphovascular involvement was noted,
with widespread blood vessel involvement seen (Figure 1a).
The spermatic cord was not involved (pT2 classification).
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extensive disease within the thorax with multiple bilat-
eral pulmonary metastases measuring up to 3 cm in
both lungs (Figure 2a). In addition there was bulky med-
iastinal adenopathy with nodes measuring up to 3.8 cm
in the prevascular space and also abnormal adenopathy
was noted in both pulmonary hilum, measuring 2.6 cm
versus 2.1 cm on the right and left, respectively. Two
prominent interaortocaval nodes measuring up to
7 mm, bilateral 8 mm external iliac and 7.5 mm right
inguinal nodes were seen. There were no significant
anatomical abnormalities of the renal tract or major ves-
sels. Postoperatively, upon catheter removal retention of
urine continued. A flexible cystoscopy examination
demonstrated a penile urethral tumor, and an incision
biopsy was performed. A suprapubic catheter was
placed. An MRI scan of the penile lesion demonstrated
bilateral inguinal nodes measuring up to 9 mm along
Figure 1 Histology: (a) Testicular tumor demonstrating vascular invasion by undifferentiated teratoma. (b) Urethral tumor demonstrating
undifferentiated teratoma. (c) Urethral tumor demonstrating positive staining for CD30 in immunohistochemistry.
Figure 2 CT Scans: (a) Pre-chemotherapy computed tomography (CT) scan of the thorax demonstrating bilateral widespread pulmonary
metastasis. (b) Post-chemotherapy CT scan of the thorax demonstrating resolution of the pulmonary metastasis.
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and bilateral internal iliac nodes smaller than 1 cm. An
8 mm pelvic lymph node adjacent to the anterolateral
aspect of the bladder was noted. There were two areas of
abnormality noted in the ischium, which gave a low sig-
nal on T1 and a high signal on the short T1 inversion
recovery (STIR) MRI sequences consistent with bony
metastasis. Within the penile shaft, 3 cm proximal to the
glans penis, a soft tissue mass was confirmed measuring
2 cm in long axis, involving both the penile corpora
(Figure 3a). A technetium bone scan showed a low-grade
tracer uptake in the left ischium corresponding to the
site of morphological abnormality on the MRI scan.
Histology of the urethral mass confirmed a metastatic
malignant undifferentiated teratoma (Figure 1b). Immu-
nochemistry was positive for placental alkaline phospha-
tase and CD30 (Figure 1c). The diagnosis was of an
International Germ Cell Cancer Collaborative Group
(IGCCCG) poor prognosis metastatic nonseminomatous
germ cell tumor. Four cycles of bleomycin, etoposide
and cisplatin chemotherapy were administered without
complication. Then, 12 weeks after starting chemother-
apy, his suprapubic catheter was clamped and he was
able to micturate per urethera. His catheter was then
removed. A reassessment CT scan of the chest and
abdomen (Figure 2b) four weeks after completion of
chemotherapy indicated excellent response to treatment.
At the site of pulmonary metastasis, there was complete
resolution of the pulmonary masses with only residual
ill-defined areas of nodularity and lacunae seen. There
was also a reduction in the size of all retroperitoneal
and pelvic lymph nodes to less than 5 mm. His serum
a-fetoprotein level fell to normal by week one post-che-
motherapy with a plasma half life of six days, his serum
b-human chorionic gonadotrophin level normalized
prior to starting chemotherapy and his lactate dehydrogen-
ase level fell to normal by week five post-chemotherapy.
A repeat MRI of the pelvis six weeks after completion of
chemotherapy indicated partial resolution of the penile
(Figure 3a) and bony lesions. A further repeat MRI scan
of the penis performed 14 weeks later confirmed further
resolution of the penile metastasis, which is now a fibro-
tic scar-like 9 mm lesion (Figure 3b). Our patient
remains in clinical, marker and radiological remission 10
months after diagnosis. His post-treatment follow-up
continues.
Discussion
Primary urethral tumors are rare, accounting for less
than 1% of urological cancers in the USA [1]. Metastatic
involvement of the urethra is also uncommon and is
mainly a result of local spread from the surrounding
organs. Germ cell tumors of the testis are the most
common solid tumors in men aged between 20 and 35
years. We are not aware of any previous reports of pre-
sentation with confirmed intraluminal metastasis to the
Figure 3 MRI Scans: (a) Pre-chemotherapy T2 sagittal thin penile MRI slices demonstrating the penile metastasis within the corpora. (b) Post-
chemotherapy T2 sagittal thin penile MRI slices showing the resolving penile lesion.
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ureteral metastasis at relapse from a recurrent testicular
seminoma [2]. According to the TNM classification [3]
a urethral metastasis represents stage M1b disease in
the absence of evidence of local spread. Our patient’s
nonpulmonary visceral metastasis (urethra and bone)
indicates a poor prognosis within the IGCCCG classifi-
cation [3].
The spread of nonseminomatous germ cell tumors
may be local, via the lymphatics or via vascular chan-
nels. Review of our patient’s primary tumor revealed
widespread blood vessel involvement. As the spermatic
cord was not involved, it is unlikely that dissemination
to the urethra represented local invasion. Seeding
through urine or seminal fluid also seems unlikely. The
involvement of ischium and inguinal lymph nodes is
also unusual and may be attributed to lymphovascular
dissemination.
In the absence of previous inguino-scrotal surgery, the
usual lymphatic drainage of the right testis is through
the interaortocaval nodes. Secondary lymphatic spread
may cross the midline, and may occur in a retrograde
fashion to the common external and inguinal nodes
involving the pelvic structures. As the distal urethra
drains into superficial and deep inguinal lymph nodes, it
could have been involved in a retrograde manner.
Spread via hematogenous dissemination is also a likely
possibility.
Conclusion
We believe this rare presentation of testicular cancer
relates to atypical lymphovascular dissemination within
the pelvis, with no history of surgical interventions that
would predispose our patient to this route of dissemina-
tion. While the presentation in this case is highly
unusual, it confirms the need to include pelvic imaging
in the initial investigation of patients with testicular can-
cer. Furthermore, patients who have demonstrated intra-
pelvic dissemination of disease need to have continued
pelvic imaging at every reassessment. Clinicians should
consider further dedicated investigation such as penile
MRI in patients presenting with urinary tract obstruc-
tion and testicular germ cell tumor.
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Written informed consent was obtained from the patient
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